ISPOR 2021 Annual Report
In 2021, ISPOR continued to advance its mission to improve healthcare decisions as the global pandemic entered its second year. The work of ISPOR members and the HEOR community makes a vital difference in healthcare and in the lives of patients.
A topline summary of some of the more notable activities and strategic initiatives over 2021 include the following:
Execution of the Strategic Plan
ISPOR continued to execute its Strategic Plan Update 2024.
ISPOR Science Strategy
The Society published the ISPOR Science Strategy that articulates the topics of greatest importance to HEOR and health systems.
Global Conferences and Events
ISPOR continued to advance its mission to promote HEOR excellence to improve decision making for health globally by executing conferences, summits, Signal episodes, short courses, roundtables, and member group meetings virtually. The Society organized its 2 annual conferences—ISPOR 2021 and ISPOR Europe 2021—as well as a Value Assessment Summit, Latin America Summit, Payer Summit, 5 Health Technology Assessment Roundtables; 4 Patient Representatives Roundtables; 32 short courses, 24 webinars, and many, many member group meetings—with these events attracting a total of more than 22,000 registrations. ISPOR also launched its new Signal Series that explores topics that will shape healthcare decision making over the next decade.
ISPOR experienced a growth in the impact factor score for ISPOR’s flagship journal, Value in Health, to 5.725.
HEOR News Brief
The Society launched ISPOR’s new HEOR News Brief enewsletter that curates HEOR-related news from sources around the world.
Good Practices Reports
ISPOR published a new Good Practices Report on the "Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes."
Calls for Comment
The Society responded to calls for comment from EUnetHTA, European Medicines Agency, and US Food and Drug Administration. Additionally, its local chapters provided advisement to numerous local governments and ministries of health throughout the year.
New Member Groups
ISPOR established a new task force for Structured Expert Elicitation for Healthcare Decision Making and a new special interest group on Health Equity.
ISPOR's global groups made "ISPOR Impact” for effective health policy around the globe through the Society’s regional chapters that contributed to their local HEOR and real-world evidence guidance, as well as national post-COVID responses.
HEOR Solutions Center
The Society launched its new HEOR Solutions Center—the marketplace for expertise.
Real-World Evidence Registry
The new Real-World Evidence Registry launched in 2021. This is an initiative of the Real-World Evidence Transparency Initiative.
The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II Task Force completed their work in preparation of publishing their updated CHEERS Report (published in the January 2022 issue of Value in Health).
Low- and Middle-Income Countries (LMICs)
ISPOR established a new LMIC Health Economics and Outcomes Research Excellence Award as part of the Society’s Low- and Middle-Income Countries (LMIC) Initiative.
Diversity in HEOR
The Society continued to make significant gains in improving diversity metrics of ISPOR’s annual conference plenary speakers.
ISPOR acknowledges its members and the diverse group of stakeholders who have helped achieve many important milestones over the past year.
Download the full annual report (below) to read the story of ISPOR and its members who contribute to the science of HEOR and help to improve healthcare decisions.
Past Annual Reports